Inovio appoints CEO Shea to board; shareholders approve auditor and exec compensation vote

INOVIO PHARMACEUTICALS, INC.

CEO Jacqueline Shea appointed to board following May 16, 2022 annual meeting; term until 2023 annual meeting.
All seven director nominees elected; highest votes for David Weiner (53.2M), lowest for Lota Zoth (48.1M for).
Ratification of Ernst & Young as auditor passed with 109.6M for, 6.7M against, 1.4M abstain.
Advisory 'say-on-pay' vote passed with 40.8M for, 16.9M against, 0.7M abstain; broker non-votes 59.2M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.